Krystal Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Krystal Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Krystal Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $6.66M, a 12.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.66M -$930K -12.3% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $6.85M -$969K -12.4% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $7.03M -$1.02M -12.6% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $7.36M -$893K -10.8% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $7.59M -$689K -8.32% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $7.81M -$639K -7.56% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $8.04M +$814K +11.3% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $8.25M +$911K +12.4% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $8.28M +$1.14M +16% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $8.45M +$5.25M +164% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $7.23M +$3.93M +119% Dec 31, 2021 10-K 2023-02-27
Q3 2021 $7.34M +$4.87M +197% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $7.14M +$4.58M +179% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $3.2M -$98K -2.97% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $3.3M +$589K +21.7% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $2.48M -$320K -11.4% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $2.56M -$351K -12.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $3.3M +$297K +9.9% Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.71M +$1.61M +146% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $2.8M Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $2.91M Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $3M Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $1.1M Jan 1, 2019 10-Q 2020-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.